Form 8-K - Current report:
SEC Accession No. 0001193125-23-040332
Filing Date
2023-02-15
Accepted
2023-02-15 17:22:33
Documents
12
Period of Report
2023-02-15
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d807348d8k.htm   iXBRL 8-K 22724
  Complete submission text file 0001193125-23-040332.txt   143162

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bhc-20230215.xsd EX-101.SCH 2520
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20230215_lab.xml EX-101.LAB 17939
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20230215_pre.xml EX-101.PRE 11230
6 EXTRACTED XBRL INSTANCE DOCUMENT d807348d8k_htm.xml XML 3447
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 23636404
SIC: 2834 Pharmaceutical Preparations